N/A
N=53
Effect of the Teleconsultation of Renal Nutrition on Renal Function and Glycemic Control in Patients With DKD
Diet Modification · Diabetic Kidney Disease · Chronic Kidney Diseases
Bottom Line
View on ClinicalTrials.gov: NCT03344549 ↗Enrolled (actual)
53
Serious AEs
3.2%
Results posted
Sep 2024
Primary outcome: Primary: Glycemic Control — 7.4; 7.35 percentage of HbA1c — p=0.37
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Renal nutrition teleconsultation (Behavioral); Face-to-face consultation of renal nutrition (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Hospital Civil Juan I. Menchaca
- Primary completion
- Oct 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Glycemic Control |
7.4; 7.35 | 0.37 |
| PRIMARY Renal Function |
34.45; 36.19 | 0.46 |
| SECONDARY Number of Participants With Adherence to Treatment |
0; 2; 15; 7; 4; 3 | 0.16 |
Summary
The modern era is characterized by progress, development and social and economic globalization. Currently the electronic technology has applications in a wide variety of work areas. A clear example of this, is telemedicine. The technological tools are increasingly used every day in the improvement of the processes and the attention in health, in the last decades, telemedicine has grown exponentially becoming more accessible to the population.
On the other hand, and in the same way, the number of people with chronic degenerative diseases such as diabetes and chronic kidney disease are increasing with alarming numbers, The health system can not offer the attention to the great demand. The strategies used until now for its management have gradually evolved towards a more effective prevention and treatment approach which requires a multidisciplinary team. Investigate the use of new tools that promise to improve the service, has also become a prevailing need. Therefore, the purpose of this study is to know the effect of nutritional teleconsultation on renal function and glycemic control of patients with Diabetic Kidney Disease (DKD) in pre-dialysis stages (specifically G3a, G3b and G4).
Eligibility Criteria
Inclusion Criteria
- Patients with diabetic kidney with eGFR <60 ml / min / 1.73m2 and ≥15 ml / min / 1.73m2, (stage G3a, G3b and G4 respectively).
- Patients who can read and write.
- Patients who have access to the internet and have a computer, tablet or smartphone.
- Patients who signed the voluntary agreement to participate.
Exclusion Criteria
- Patients who have received prior nutritional treatment for the control of diabetic kidney disease.
- Patients with actual consumption of food supplements and / or keto analogues.
- Patients with anemia or recent transfusions (in the last 3 months).
- Patients with serious complications (chronic infection, septicemia, cancer, HIV, Alzheimer's, uncontrolled heart failure, liver failure, etc.).
- Patients with serious difficulties in communication or intellectual deficit that impedes the ability to understand the intervention.
- Patients with refractory arterial hypertension.
- Patients who do not attend ≥ 2 nutritional interventions.
- Patients who present serious complications during the intervention (chronic infection, septicemia, cancer, HIV, Alzheimer's, uncontrolled heart failure, liver failure, etc.).
Data sourced from ClinicalTrials.gov (NCT03344549). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.